Health Condition 1: C55- Malignant neoplasm of uterus, partunspecified
Conditions
Interventions
Intervention1: Intrathecal morphine: Patients will receive intrathecal morphine 5 mcg/kg in 1 ml normal saline along with thoracic epidural and General Anaesthesia
Control Intervention1: Epidural morp
Sponsors
Delhi State Cancer Institute
Eligibility
Inclusion criteria
Inclusion criteria: ASA I-III, undergoing elective laparotomy for gynecologic malignancy under anesthesia
Exclusion criteria
Exclusion criteria: Patient with infection at the site of injection for central neuraxial block, coagulopathy, spine deformity, pre-existing neurological deficit, history of chronic pain, patients on opioids preoperatively, drug addicts, use of analgesia in last 48 hrs before surgery, previous abdominal surgeries, psychiatric disease, liver disease, cardiac disease, renal failure, patients requiring postoperative mechanical ventilation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total fentanyl consumption intraoperatively and postoperatively in 24 hrsTimepoint: Total fentanyl consumption intraoperatively and postoperatively in 24 hrs | — |
Secondary
| Measure | Time frame |
|---|---|
| NRS at rest every hourly upto 24 hrsTimepoint: every hourly postoperatively upto 24 hrs;Duration of effective analgesiaTimepoint: postoperatively;Adverse effectsTimepoint: upto 24 hrs postoperatively;Patient satisfactionTimepoint: 24 hrs postoperatively | — |
Countries
India
Contacts
Public ContactDr Anuradha Patel
Delhi State Cancer Institute
Outcome results
None listed